TRCT
NXTC icon

Tower Research Capital (TRC)’s NextCure NXTC Stock Holding History

Tower Research Capital (TRC)’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78K Buy
+1,738
New +$12.8K ﹤0.01% 4617
2025
Q3 		– Sell
-127
Closed -$703 – 5490
2025
Q2 		$703 Sell
127
-29
-19% -$156 ﹤0.01% 4958
2025
Q1 		$898 Buy
156
+101
+184% +$891 ﹤0.01% 4808
2024
Q4 		$508 Buy
+55
New +$809 ﹤0.01% 5250
2024
Q3 		– Sell
-102
Closed -$1.95K – 5906
2024
Q2 		$1.95K Sell
102
-88
-46% -$1.71K ﹤0.01% 5072
2024
Q1 		$5.07K Sell
190
-484
-72% -$8.34K ﹤0.01% 4588
2023
Q4 		$9.22K Buy
674
+87
+15% +$1.26K ﹤0.01% 4422
2023
Q3 		$9.09K Buy
587
+282
+92% +$5.38K ﹤0.01% 4268
2023
Q2 		$6.58K Sell
305
-870
-74% -$17.1K ﹤0.01% 4682
2023
Q1 		$21K Sell
1,175
-586
-33% -$11.3K ﹤0.01% 3390
2022
Q4 		$30K Buy
1,761
+396
+29% +$9.11K ﹤0.01% 2748
2022
Q3 		$45K Buy
1,365
+684
+100% +$34.9K ﹤0.01% 3260
2022
Q2 		$38K Sell
681
-858
-56% -$44.8K ﹤0.01% 3145
2022
Q1 		$90K Buy
1,539
+1,256
+444% +$78.6K ﹤0.01% 2291
2021
Q4 		$20K Sell
283
-94
-25% -$7.86K ﹤0.01% 3675
2021
Q3 		$31K Buy
377
+162
+75% +$14.2K ﹤0.01% 3357
2021
Q2 		$21K Buy
215
+41
+24% +$4.2K ﹤0.01% 3850
2021
Q1 		$21K Sell
174
-320
-65% -$46.3K ﹤0.01% 3844
2020
Q4 		$65K Sell
494
-920
-65% -$119K ﹤0.01% 2821
2020
Q3 		$149K Buy
1,414
+1,219
+625% +$150K ﹤0.01% 2822
2020
Q2 		$50K Buy
195
+166
+572% +$63.2K ﹤0.01% 3047
2020
Q1 		$13K Buy
29
+21
+263% +$11.2K ﹤0.01% 1912
2019
Q4 		$6K Sell
8
-24
-75% -$12K ﹤0.01% 2603
2019
Q3 		$12K Sell
32
-499
-94% -$162K ﹤0.01% 2831
2019
Q2 		$96K Buy
+531
New +$110K 0.01% 1197

Other funds holding NXTC

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
VA
Verdad Advisers Boston, Massachusetts $104M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Tower Research Capital (TRC)'s NXTC Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in NextCure (NXTC) in Q2 2026: 1,738 shares worth $2.78K. The stake represents ﹤0.01% of the portfolio and ranks #4617 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in NXTC as recently as Q2 2025.

Tower Research Capital (TRC) first reported a position in NXTC in Q2 2019 and has held it in 25 quarters since. The position peaked at $149K in Q3 2020. 30 funds tracked by Wall St. Rank hold NXTC as of Q2 2026.

  • Tower Research Capital (TRC) held 1,738 shares of NextCure worth $2.78K as of Q2 2026.
  • NextCure was a new Tower Research Capital (TRC) position in Q2 2026.
  • NextCure made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4617 holding.
  • Tower Research Capital (TRC) first reported a position in NextCure in Q2 2019 and has held it in 25 quarters since.
  • Tower Research Capital (TRC)'s NextCure position peaked at $149K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held NextCure as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.